DENVER--(BUSINESS WIRE)--Accelr8 Technology Corporation (Amex: AXK) announced today that two teams of university research collaborators report new methods for scalable production with the company’s patented OptiChem® bio-coatings. Led by Dr. David Grainger at the University of Utah, researchers from the University of Utah, the University of Washington, and Accelr8 developed production-scalable methods to make OptiChem surface micro-patterns for live-cell and biomolecular attachment. The new study overcame the technical obstacles that have limited previous high-performance, patterned bio-coatings to laboratory-scale fabrication.
